Novozymes A/S (OTCMKTS:NVZMY – Get Free Report)’s share price gapped up prior to trading on Friday . The stock had previously closed at $52.81, but opened at $54.53. Novozymes A/S shares last traded at $54.3620, with a volume of 19,063 shares changing hands.
Novozymes A/S Trading Up 2.5%
The firm has a market capitalization of $22.43 billion, a P/E ratio of 38.65, a price-to-earnings-growth ratio of 0.98 and a beta of 1.11. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.61 and a quick ratio of 1.00. The firm has a fifty day simple moving average of $60.17 and a two-hundred day simple moving average of $61.66.
Novozymes A/S (OTCMKTS:NVZMY – Get Free Report) last posted its quarterly earnings data on Wednesday, February 25th. The biotechnology company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.79 by ($0.44). Novozymes A/S had a return on equity of 6.38% and a net margin of 13.96%.The firm had revenue of $1.18 billion for the quarter, compared to the consensus estimate of $1.22 billion. On average, equities research analysts anticipate that Novozymes A/S will post 1.82 earnings per share for the current fiscal year.
Novozymes A/S Company Profile
Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.
The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).
See Also
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
